Items Tagged ‘Cardiovascular Disease’

August 25, 2020

Largest pharmacogenetics clinical trial in cardiology shows potential benefit in individualized approach to anti-platelet therapy

By Susan Murphy Susan Murphy

By Terri Malloy Heart patients who undergo percutaneous coronary intervention (PCI) or stent placement― nonsurgical procedures to improve blood flow to the heart ― are typically prescribed anti-platelet therapy to avoid blood clots that can lead to a heart attack or stroke. New research from the international TAILOR-PCI trial, the largest pharmacogenetics clinical trial in […]

View full entry

Tags: #cardiology, Cardiovascular Disease, individualized medicine, pharmacogenomics


July 1, 2020

Mayo researchers earn NIH award to study use of genetic risk scores for heart disease in diverse populations

By Susan Murphy Susan Murphy

In recognition of their high impact work of advancing the field of genetic risk profiling for disease risk stratification, the National Institutes of Health (NIH) has awarded Mayo Clinic researchers Iftikhar Kullo, M.D. and Richard Sharp Ph.D. part of $75 million in funding over five years to improve the role of genomics in assessing and […]

View full entry

Tags: Bioethics, Cardiovascular Disease, Genetics


February 13, 2018

Genetic cardiovascular disease: Is your family at risk?

By Susan Buckles Susan Buckles

With cardiovascular disease a leading cause of death, it’s fair to say that many people have been touched by this disorder. Maybe a family member died suddenly of a heart attack, or a friend suffered a disabling stroke. February is American Heart Month, a great time to talk about the precision approach Mayo Clinic Center […]

View full entry

Tags: #Familial hypercholesterolemia, #FH, #Genetic risk, #High cholesterol, #Mayo Clinic Department of Cardioscular Diseases, #Mayo Clinic Department of Clinical Genomics, #Stroke, Cardiovascular Disease, Dr. Iftikhar Kullo, Genetic Testing, heart attack, Heart Disease


July 25, 2017

Workshops to offer practical ways to apply genomic medicine to improve care

By Sharon Rosen Sharon Rosen

Genetic testing is increasingly used in new ways to improve diagnosis and treatment for many conditions such as advanced cancers, cardiovascular diseases and gastrointestinal disorders. Post conference sessions at this year’s Individualizing Medicine 2017: Advancing Care Through Genomics are offered to help providers and patients learn how they can tap into these promising new technologies. […]

View full entry

Tags: #cardiovascular genomics, #CIMCon17, #continuing medical education, #gastronintestinal diseases, #genetic disorders, #Individualizing Medicine 2017, #liver diseases, #Lysomal disease, #medical education, #rare genetic diseases, #rare genetic disorders, Cardiovascular Disease


November 14, 2013

Genomics Of Antiplatelet Heart Medication Study At Mayo Clinic

By AJ Montpetit AJ Montpetit

Which antiplatelet medication is best after a coronary stent? The costly and potential life-or-death question lingers after most of the 600,000 angioplasties performed every year in the United States. The answer may lie in your genes, but professional cardiovascular societies and many working cardiologists question the U.S. Food and Drug Administration’s recent recommendation that patients undergo genetic testing before taking Plavix (clopidogrel bisulfate). The […]

View full entry

Tags: antiplatelet, Cardiovascular Disease, center for individualized medicine, Genetic Testing, genome, genomics, heart medication, individualized medicine, mayo clinic, Naveen Pereira, personalized care, Personalized Medication


Contact Us · Privacy Policy